Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rangering i aksjer #41418
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Aksjekurs
$0.0001
Sist synkronisert: 2025-06-11
Markedsverdi
$21.52K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
CA
Handel Diagnocure, Inc. (DGCRF)

Kategori

Pris DGCRF pris med markedsverdi på B
Diagnocure, Inc. Diagnocure, Inc.
DGCRF
$0.0001
Markedsverdi av Diagnocure, Inc.(DGCRF)
Markedsverdi: $21.52K
Per August 2026 har Diagnocure, Inc. en markedsverdi på $21.52K. Dette gjør Diagnocure, Inc. til det 41418th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Diagnocure, Inc. fra 2012 til 2026
DGCRF sammenlignet med topp 5 mest populære stocks
Pris på DGCRF Eiendel B Markedsverdi for B Resultater
Diagnocure, Inc. Diagnocure, Inc.
$25,015.61 $21.52K
$5.383T +25,015,610,773.61%
Diagnocure, Inc. Diagnocure, Inc.
$20,554.79 $21.52K
$4.423T +20,554,791,738.93%
Diagnocure, Inc. Diagnocure, Inc.
$19,332.57 $21.52K
$4.160T +19,332,571,457.07%
Diagnocure, Inc. Diagnocure, Inc.
$17,022.87 $21.52K
$3.663T +17,022,866,242.94%
Diagnocure, Inc. Diagnocure, Inc.
$13,435.08 $21.52K
$2.891T +13,435,077,945.54%